CANADA LIFE ASSURANCE Co - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$485,000
+21.6%
2,800
-12.0%
0.00%0.0%
Q2 2021$399,000
-8.3%
3,181
-1.6%
0.00%0.0%
Q1 2021$435,000
-3.1%
3,232
-8.4%
0.00%0.0%
Q4 2020$449,000
+28.3%
3,530
+13.4%
0.00%0.0%
Q3 2020$350,000
+18.6%
3,1140.0%0.00%0.0%
Q2 2020$295,000
+4.6%
3,1140.0%0.00%0.0%
Q1 2020$282,000
+72.0%
3,1140.0%0.00%
Q4 2019$164,000
-32.2%
3,114
-47.1%
0.00%
-100.0%
Q2 2019$242,000
-24.6%
5,890
-14.9%
0.00%0.0%
Q1 2019$321,000
+50.7%
6,923
+36.3%
0.00%0.0%
Q4 2018$213,000
-26.8%
5,0800.0%0.00%0.0%
Q3 2018$291,000
+18.3%
5,0800.0%0.00%0.0%
Q2 2018$246,000
+23.6%
5,0800.0%0.00%
Q1 2018$199,000
-7.4%
5,0800.0%0.00%
-100.0%
Q4 2017$215,000
+128.7%
5,080
+93.5%
0.00%
Q3 2017$94,000
+17.5%
2,6250.0%0.00%
Q2 2017$80,000
+15.9%
2,6250.0%0.00%
Q1 2017$69,000
+3.0%
2,6250.0%0.00%
Q4 2016$67,000
-64.7%
2,625
-50.0%
0.00%
Q3 2016$190,000
+113.5%
5,250
+100.0%
0.00%
Q2 2016$89,000
-37.3%
2,625
-51.4%
0.00%
-100.0%
Q1 2016$142,000
+79.7%
5,397
+231.1%
0.00%
Q4 2015$79,000
+92.7%
1,6300.0%0.00%
Q3 2015$41,000
-19.6%
1,6300.0%0.00%
Q2 2015$51,000
-17.7%
1,6300.0%0.00%
Q1 2015$62,0001,6300.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders